Newstral
Article
POLITICO on 2021-01-28 23:27
Novavax says its Covid-19 vaccine is 89 percent effective, but less so against South African variant
Related news
- BNovavax Says Its Vaccine Is 89% Effective in Britain--but Not as Effective Against the South African Variantbarrons.com
- Study: Novavax COVID-19 vaccine appears 89% effectiveisraelnationalnews.com
- Novavax COVID vaccine highly effective — except against South African strainNew York Post
- Novavax says its COVID-19 vaccine is 90 percent effectiveThe Verge
- Novavax Covid Vaccine Is Highly Effective Against U.K. Variant But Struggled In South Africa, Data ShowsForbes
- Study: Pfizer vaccine effective in neutralizing South African variantisraelnationalnews.com
- New study shows vaccine effective against South African variantisraelnationalnews.com
- Novavax vaccine 96% effective against original coronavirus, 86% for British variant in U.K. trialThe Hindu
- Novavax coronavirus vaccine highly effective, but not against South Africa variantSouth China Morning Post
- Novavax says Covid-19 vaccine is 89% effective in UK trial, but less so in South AfricaCNN
- HHealth Ministry Official: Unsure How Effective Vaccine Is Against South African Varianthamodia.com
- COVID-19: AstraZeneca vaccine less effective against South African variant – Studyvanguardngr.com
- Pfizer says vaccine effective for at least 6 months, protects against S. African variantpressherald.com
- HStudy: Oxford/AstraZeneca COVID Shot Less Effective Against S. African Varianthamodia.com
- Novavax coronavirus vaccine 89% effective, but less so against variantsKVUE News
- Novavax vaccine seems effective against COVID-19 in UK studySeattle Times
- 'Vaccine is less effective against South African variant'israelnationalnews.com
- Novavax: Large study finds COVID-19 shot about 90% effectivelasvegassun.com
- Novavax COVID-19 vaccine proves effective, but less so against variantspressherald.com